Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078480752> ?p ?o ?g. }
- W2078480752 endingPage "1635" @default.
- W2078480752 startingPage "1630" @default.
- W2078480752 abstract "Loratadine was studied both in vitro and in vivo (in healthy humans) to classify it according to the Biopharmaceutics Classification System (BCS) in order to gain more understanding of the reasons for its highly variable nature with respect to plasma time profiles, and to determine the most appropriate dissolution test conditions for in vitro assessment of the release profile of the drug from solid dose forms. Based on the solubility of loratadine determined under various pH conditions and its permeability through Caco-2 monolayers, loratadine was classified as a Class II drug. Plasma profiles were predicted by convolution analysis using dissolution profiles obtained under various pH and hydrodynamic conditions as the input function and plasma time data obtained from a syrup formulation as the weighting function. The predicted profiles based on dissolution studies done at gastric pH values were in reasonable agreement with the mean bio-data suggesting dissolution testing should be done at gastric pH values. However, the bio-data were highly variable and it is suggested this may be due, at least in part, to high individual gastric pH variability and dissolution occurring in the intestine on some occasions, and therefore, dissolution testing should also be done in simulated intestinal fluid." @default.
- W2078480752 created "2016-06-24" @default.
- W2078480752 creator A5017232542 @default.
- W2078480752 creator A5028055294 @default.
- W2078480752 creator A5029529336 @default.
- W2078480752 creator A5037817845 @default.
- W2078480752 creator A5061692267 @default.
- W2078480752 creator A5065779879 @default.
- W2078480752 creator A5073943479 @default.
- W2078480752 creator A5081347584 @default.
- W2078480752 creator A5084267935 @default.
- W2078480752 date "2004-01-01" @default.
- W2078480752 modified "2023-10-16" @default.
- W2078480752 title "Classification of Loratadine Based on the Biopharmaceutics Drug Classification Concept and Possible in Vitro-in Vivo Correlation" @default.
- W2078480752 cites W1488110678 @default.
- W2078480752 cites W1498305210 @default.
- W2078480752 cites W1499768710 @default.
- W2078480752 cites W1521545709 @default.
- W2078480752 cites W1522767714 @default.
- W2078480752 cites W1526950891 @default.
- W2078480752 cites W1970057581 @default.
- W2078480752 cites W1997360771 @default.
- W2078480752 cites W2061164789 @default.
- W2078480752 cites W2076708105 @default.
- W2078480752 cites W2089407496 @default.
- W2078480752 cites W2095616344 @default.
- W2078480752 cites W2103070854 @default.
- W2078480752 cites W30775475 @default.
- W2078480752 doi "https://doi.org/10.1248/bpb.27.1630" @default.
- W2078480752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15467209" @default.
- W2078480752 hasPublicationYear "2004" @default.
- W2078480752 type Work @default.
- W2078480752 sameAs 2078480752 @default.
- W2078480752 citedByCount "55" @default.
- W2078480752 countsByYear W20784807522012 @default.
- W2078480752 countsByYear W20784807522013 @default.
- W2078480752 countsByYear W20784807522014 @default.
- W2078480752 countsByYear W20784807522015 @default.
- W2078480752 countsByYear W20784807522016 @default.
- W2078480752 countsByYear W20784807522017 @default.
- W2078480752 countsByYear W20784807522018 @default.
- W2078480752 countsByYear W20784807522019 @default.
- W2078480752 countsByYear W20784807522020 @default.
- W2078480752 countsByYear W20784807522021 @default.
- W2078480752 countsByYear W20784807522022 @default.
- W2078480752 countsByYear W20784807522023 @default.
- W2078480752 crossrefType "journal-article" @default.
- W2078480752 hasAuthorship W2078480752A5017232542 @default.
- W2078480752 hasAuthorship W2078480752A5028055294 @default.
- W2078480752 hasAuthorship W2078480752A5029529336 @default.
- W2078480752 hasAuthorship W2078480752A5037817845 @default.
- W2078480752 hasAuthorship W2078480752A5061692267 @default.
- W2078480752 hasAuthorship W2078480752A5065779879 @default.
- W2078480752 hasAuthorship W2078480752A5073943479 @default.
- W2078480752 hasAuthorship W2078480752A5081347584 @default.
- W2078480752 hasAuthorship W2078480752A5084267935 @default.
- W2078480752 hasBestOaLocation W20784807521 @default.
- W2078480752 hasConcept C116073593 @default.
- W2078480752 hasConcept C14029885 @default.
- W2078480752 hasConcept C147789679 @default.
- W2078480752 hasConcept C150903083 @default.
- W2078480752 hasConcept C155574463 @default.
- W2078480752 hasConcept C160492267 @default.
- W2078480752 hasConcept C178790620 @default.
- W2078480752 hasConcept C181389837 @default.
- W2078480752 hasConcept C185592680 @default.
- W2078480752 hasConcept C202751555 @default.
- W2078480752 hasConcept C207001950 @default.
- W2078480752 hasConcept C2779484521 @default.
- W2078480752 hasConcept C2780035454 @default.
- W2078480752 hasConcept C2780734495 @default.
- W2078480752 hasConcept C2781430271 @default.
- W2078480752 hasConcept C2910701995 @default.
- W2078480752 hasConcept C43617362 @default.
- W2078480752 hasConcept C55493867 @default.
- W2078480752 hasConcept C71924100 @default.
- W2078480752 hasConcept C77281830 @default.
- W2078480752 hasConcept C86803240 @default.
- W2078480752 hasConcept C88380143 @default.
- W2078480752 hasConcept C98274493 @default.
- W2078480752 hasConceptScore W2078480752C116073593 @default.
- W2078480752 hasConceptScore W2078480752C14029885 @default.
- W2078480752 hasConceptScore W2078480752C147789679 @default.
- W2078480752 hasConceptScore W2078480752C150903083 @default.
- W2078480752 hasConceptScore W2078480752C155574463 @default.
- W2078480752 hasConceptScore W2078480752C160492267 @default.
- W2078480752 hasConceptScore W2078480752C178790620 @default.
- W2078480752 hasConceptScore W2078480752C181389837 @default.
- W2078480752 hasConceptScore W2078480752C185592680 @default.
- W2078480752 hasConceptScore W2078480752C202751555 @default.
- W2078480752 hasConceptScore W2078480752C207001950 @default.
- W2078480752 hasConceptScore W2078480752C2779484521 @default.
- W2078480752 hasConceptScore W2078480752C2780035454 @default.
- W2078480752 hasConceptScore W2078480752C2780734495 @default.
- W2078480752 hasConceptScore W2078480752C2781430271 @default.
- W2078480752 hasConceptScore W2078480752C2910701995 @default.
- W2078480752 hasConceptScore W2078480752C43617362 @default.
- W2078480752 hasConceptScore W2078480752C55493867 @default.